Advertisements


Pacific Biosciences" Sequel Sees Solid Q2, Competition Rife

Pacific Biosciences (P.....»»

Category: worldSource: nytAug 10th, 2018

Pacific Biosciences Gains as HudsonAlpha Picks Sequel System

Pacific Biosciences (PACB) sees increasing use of Sequel Sequencing System in pediatric and plant biologic case studies. Pacific Biosciences of Califo.....»»

Category: personnelSource: nytApr 12th, 2018

NuVasive"s (NUVA) Global Prospects Solid, Competition Rife

NuVasive (NUVA) demonstrates strong sales growth across all geographies. Competitive landscape is a concern. On Jun 4, we issued an updated research report on NuVasive, Inc. NUVA. We are upbeat.....»»

Category: personnelSource: nytJun 5th, 2018

Pacific Biosciences Sequel installs could be light in Q1, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 13th, 2018

Currencies: Dollar heads for first weekly loss in a month; yuan lifted by trade talks news

The U.S. dollar index sees a solid pullback on Friday, notably against the euro and the British pound, putting the gauge on track for a 0.2% loss this week—its worst performance in about a month, according to FactSet......»»

Category: topSource: marketwatchAug 17th, 2018

Uber Sees A 38% Yearly Increase In Gross Bookings As It Gears Up To Face Competition

Though a privately-held company, Uber Inc. chooses to announce its quarterly earnings to investors and the p.....»»

Category: earningsSource: benzingaAug 16th, 2018

Uber Sees A 38% Yearly Increase In Gross Bookings As It Gears Up To Face Competition

Though a privately-held company, Uber Inc. chooses to announce its quarterly earnings to investors and the public. The ride-hailing giant has reported a loss of $891 million in Q2 2018, but showed increased revenue to the tune of $2.8 billion. read more.....»»

Category: blogSource: benzingaAug 16th, 2018

Genocea Biosciences Sees Hammer Chart Pattern: Time to Buy?

Genocea Biosciences has been strugg.....»»

Category: worldSource: nytAug 16th, 2018

Why Merrill Lynch Sees Health Care Sector Offering Solid Growth, and as Value and Defensive

The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks......»»

Category: blogSource: 247wallstAug 15th, 2018

Solid Demand, Pricing Strategy Bode Well for Louisiana-Pacific

Robust demand for its products, courtesy of housing market strength, has been a major growth driver for Louisiana-Pacific (LPX). Strong housing market, bold pricing strategy along with efficient cost-saving plans have .....»»

Category: dealsSource: nytAug 13th, 2018

The Marines are preparing for a potential "big-ass fight," and they may soon be spending more time in Alaska

US Marine Corps/Lance Cpl. Tanner Seims The Pentagon has been reorienting its forces for what it sees as emerging great-power competition wi.....»»

Category: topSource: businessinsiderAug 10th, 2018

Solid Biosciences reports Q2 EPS (52c), consensus (51c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Cantor starts Pacific Biosciences with Overweight rating, $5 target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 9th, 2018

Pacific Biosciences initiated with an Overweight at Cantor Fitzgerald

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 8th, 2018

Cronos Group CEO sees competition intensifying as cannabis industry matures

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 3rd, 2018

Pacific Biosciences of California (PACB) CEO Mike Hunkapiller on Q2 2018 Results - Earnings Call Transcript

Pacific Biosciences of California (PACB) CEO Mike Hunkapiller on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaAug 2nd, 2018

Pacific Biosciences reports Q2 EPS (17c), consensus (17c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 2nd, 2018

CONMED (CNMD) Beats on Q2 Earnings, Raises 2018 Guidance

CONMED (CNMD) sees solid domestic and international sales in Q2; raised guidance e.....»»

Category: dealsSource: nytAug 2nd, 2018

Oshkosh CEO sees "solid results to close out fiscal 2018"

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2018

MUFG sees "solid" Q2 for Welltower despite persistent near-term challenges

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 29th, 2018

Here"s Why Pacific Biosciences Tumbled 10% Today

Investors are taking a cautious stance ahead of earnings next week and an ongoing trade spat with China......»»

Category: topSource: foxnewsJul 27th, 2018